日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity

EPZ011989,一种高效、口服有效的EZH2抑制剂,具有显著的体内活性。

Campbell, John E; Kuntz, Kevin W; Knutson, Sarah K; Warholic, Natalie M; Keilhack, Heike; Wigle, Tim J; Raimondi, Alejandra; Klaus, Christine R; Rioux, Nathalie; Yokoi, Akira; Kawano, Satoshi; Minoshima, Yukinori; Choi, Hyeong-Wook; Porter Scott, Margaret; Waters, Nigel J; Smith, Jesse J; Chesworth, Richard; Moyer, Mikel P; Copeland, Robert A

Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma

磷脂酰肌醇蛋白聚糖-3 靶向 89Zr PET 肝细胞癌成像

Jonathan G Sham, Forrest M Kievit, John R Grierson, Robert S Miyaoka, Matthew M Yeh, Miqin Zhang, Raymond S Yeung, Satoshi Minoshima, James O Park

Magnetically targeted viral envelopes: a PET investigation of initial biodistribution

磁靶向病毒包膜:PET 初步生物分布研究

Jennifer A Flexman, Donna J Cross, Barbara L Lewellen, Sosuke Miyoshi, Yongmin Kim, Satoshi Minoshima